Lakewood-Amedex Biotherapeutics, Inc. (LABT) — Form S-1: Registration statement

About this filing

Lakewood-Amedex Biotherapeutics, Inc. (LABT) filed Form S-1 (registration statement) with the SEC on Sep 18, 2026. An S-1 registers new shares with the SEC, often ahead of a public offering.